Why Novo/Eli Lilly stock have bad ratings when there’s a big demand for ozempic

I see the ratings from several firms giving these two companies very low rankings stock wise. These two are the companies that produce ozempic/etc and it seems they can’t keep up with demand, not to mention future demand for obesity. I couldn’t find mu…